medalphabetМедицинский алфавитMedical alphabet2078-56312949-2807ООО «Альфмед»10.33667/2078-5631-2023-31-43-46medalphabet-3450Research ArticleСтатьиПоражение суставов и позвоночника у больных воспалительными заболеваниями кишечникаJoint and spine damage in patients with inflammatory bowel diseaseshttps://orcid.org/0000-0002-8974-836XТарасоваД. Д.TarasovaD. D.

Тарасова Дарья Дмитриевна - ассистент кафедры госпитальной терапии, ВПТ.

Волгоград

Daria D. Tarasova - assistant at Dept of Hospital, Military and Field Therapy.

Volgograd

bdd_34@mail.ruhttps://orcid.org/0000-0002-0438-8554ШиловаЛ. Н.ShilovaL. N.

Шилова Людмила Николаевна - д.м.н., зав. кафедрой госпитальной терапии, ВПТ.

Волгоград

Lyudmila N. Shilova - DM Sci (habil.), head of Dept of Hospital, Military and Field Therapy.

Volgograd

ФГБОУ ВО «Волгоградский государственный медицинский университет» Минздрава РоссииРоссияVolgograd State Medical UniversityRussian Federation202313012024031Ревматология в общей врачебной практике (2)4346Copyright © Тарасова Д.Д., Шилова Л.Н., 20242024Тарасова Д.Д., Шилова Л.Н.Tarasova D.D., Shilova L.N.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-alphabet.com/jour/article/view/3450

Поражение суставов и позвоночника является частым внекишечным проявлением (ВКП) воспалительных заболеваний кишечника (ВЗК). Исследования показывают генетическую и иммунологическую связь поражения суставов и кишечного воспаления. Могут развиваться олиго- и полиартриты мелких и крупных суставов, артралгии, анкилозирующий спондилит (АС). Артриты при ВЗК являются серонегативными, характеризуются неэрозивным и недеструктивным поражением. Суставной синдром чаще ассоциирован с тяжелым течением ВЗК и большой протяженностью поражения. Артрит при ВЗК в основном дебютирует одновременно с кишечным воспалением или возникает после, но может предшествовать развитию ВЗК. Поражение суставов может дебютировать с развернутой клинической картиной, также описаны случаи латентного течения, что осложняет своевременную постановку диагноза. Сочетание суставного синдрома и кишечного воспаления требует междисциплинарного подхода.

Damage to the joints and spine is a frequent extra-intestinal manifestation of inflammatory bowel diseases (IBD). Studies show a genetic and immunological link between joint damage and intestinal inflammation. Oligo- and polyarthritis of small and large joints, arthralgia, ankylosing spondylitis may develop. Arthritis in IBD is seronegative, characterized by non-erosive and non-destructive lesions. Articular syndrome is more often associated with a severe course of IBD and a large extent of the lesion. Arthritis with IBD, basically, debuts simultaneously with intestinal inflammation or occurs after, but may precede the development of IBD. Joint damage can make its debut with a detailed clinical picture, cases of latent course are also described, which complicates the timely diagnosis. The combination of joint syndrome and intestinal inflammation requires an interdisciplinary approach.

анкилозирующий спондилитязвенный колитболезнь Кронавнекишечные проявленияпоражение суставовankylosing spondylitisulcerative colitisCrohn's diseaseextra-intestinal manifestationsjoint damageReferencesFragoulis G.E. et al. Inflammatory bowel diseases and spondyloarthropathies: From pathogenesis to treatment. World Journal of Gastroenterology. 2019. V. 25. No. 18. P. 2162.Fragoulis G.E. et al. Inflammatory bowel diseases and spondyloarthropathies: From pathogenesis to treatment. World Journal of Gastroenterology. 2019. V. 25. No. 18. P. 2162.Kuhn K. A. et al. Bacteroidales recruit IL-6-producing intraepithelial lymphocytes in the colon to promote barrier integrity. Mucosal Immunology. 2018. V. 11. No. 2. P. 357–368.Kuhn K. A. et al. Bacteroidales recruit IL-6-producing intraepithelial lymphocytes in the colon to promote barrier integrity. Mucosal Immunology. 2018. V. 11. No. 2. P. 357–368.Frank D. N. et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proceedings of the national academy of sciences. 2007. V. 104. No. 34. P. 13780–13785.Frank D. N. et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proceedings of the national academy of sciences. 2007. V. 104. No. 34. P. 13780–13785.Шелыгин Ю. А. и др. Клинические рекомендации. Болезнь Крона (К50), взрослые. Колопроктология. 2023. Т. 22. № 3. С. 10–49. https://doi.org/10.33878/2073–7556–2023–22–3–10–49Shelygin Yu.A., at al. Clinical guidelines. Crohn’s disease (К50), adults. Koloproktologia. 2023; 22 (3): 10–49. https://doi.org/10.33878/2073–7556–2023–22–3–10–49Vavricka S.R. et al. Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Official Journal of the American College of Gastroenterology. ACG. 2011. V. 106. No. 1. P. 110–119.Vavricka S.R. et al. Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Official Journal of the American College of Gastroenterology. ACG. 2011. V. 106. No. 1. P. 110–119.Dorofeyev A.E., Vasilenko I.V., Rassokhina O.A. Joint extraintestinal manifestations in ulcerative colitis. Digestive Diseases. 2009. V. 27. No. 4. P. 502–510.Dorofeyev A.E., Vasilenko I.V., Rassokhina O.A. Joint extraintestinal manifestations in ulcerative colitis. Digestive Diseases. 2009. V. 27. No. 4. P. 502–510.Zippi M. et al. Extraintestinal manifestations in a large series of Italian inflammatory bowel disease patients. World Journal of Gastroenterology: WJG. 2014. V. 20. No. 46. P. 17463.Zippi M. et al. Extraintestinal manifestations in a large series of Italian inflammatory bowel disease patients. World Journal of Gastroenterology: WJG. 2014. V. 20. No. 46. P. 17463.Белоусова Е. А. и др. Социально-демографическая характеристика, особенности течения и варианты лечения воспалительных заболеваний кишечника в России. Результаты двух многоцентровых исследований. Альманах клинической медицины. 2018. Т. 46. № 5. С. 445–463. DOI: 10.18786/2072–0505–2018–46–5–445–463.Belousova EA at al. Social and demographic characteristics, Features of disease course and treatment options of inflammatory bower disease in Russia: Results of two multicenter studies. Almanac of Clinical Medicine. 2018; 46 (5): 445–63. DOI: 10.18786/2072–0505–2018–46–5–445–463.The First European Evidence-based Consensus on Extra-Intestinal Manifestations in IBD. Journal of Crohn's and Colitis – 2016. No. 10 (3). Pр. 239–254.The First European Evidence-based Consensus on Extra-Intestinal Manifestations in IBD. Journal of Crohn's and Colitis – 2016. No. 10 (3). Pр. 239–254.Sieper J. Axial spondyloarthritis. J. Sieper, D. Poddubnyy. Lancet. 2017. No. 390 (10089). P. 73–84.Sieper J. Axial spondyloarthritis. J. Sieper, D. Poddubnyy. Lancet. 2017. No. 390 (10089). P. 73–84.Российские клинические рекомендации. Ревматология. Под ред. Е. Л. Насонова. М.: ГЭОТАР-Медиа; 2017. 464 с.Russian clinical guidelines. Rheumatology. Ed. E.L. Nasonov. M.: GEOTAR-Media; 2017. 464 p.Karreman M.C. et al. The prevalence and incidence of axial and peripheral spondyloarthritis in inflammatory bowel disease: A systematic review and meta-analysis. Journal of Crohn's and Colitis. 2017. Т. 11. No. 5. P. 631–642.Karreman M.C. et al. The prevalence and incidence of axial and peripheral spondyloarthritis in inflammatory bowel disease: A systematic review and meta-analysis. Journal of Crohn's and Colitis. 2017. Т. 11. No. 5. P. 631–642.Sepriano A., Rubio R., Ramiro S., Landewé R., van der Heijde D. Performance of the ASAS classification criteria for axial and peripheral spondyloarthritis: A systematic literature review and meta-analysis. Ann Rheum Dis. 2017; 76: 886–90. DOI: 10.1136/annrheumdis-2016–210747.Sepriano A., Rubio R., Ramiro S., Landewé R., van der Heijde D. Performance of the ASAS classification criteria for axial and peripheral spondyloarthritis: A systematic literature review and meta-analysis. Ann Rheum Dis. 2017; 76: 886–90. DOI: 10.1136/annrheumdis-2016–210747.Brakenhoff L. The joint-gut axis in inflammatory bowel diseases. L. Brakenhoff, D.M. van der Heijde, D.W. Hommes [et al.]. Journal of Crohn’s and Colitis. 2010. No. 4. P. 257–268.Brakenhoff L. The joint-gut axis in inflammatory bowel diseases. L. Brakenhoff, D.M. van der Heijde, D.W. Hommes [et al.]. Journal of Crohn’s and Colitis. 2010. No. 4. P. 257–268.Rogler G. et al. Extraintestinal manifestations of inflammatory bowel disease: Current concepts, treatment, and implications for disease management. Gastroenterology. 2021. V. 161. No. 4. P. 1118–1132.Rogler G. et al. Extraintestinal manifestations of inflammatory bowel disease: Current concepts, treatment, and implications for disease management. Gastroenterology. 2021. V. 161. No. 4. P. 1118–1132.Greenstein A. Extra-intestinal complications of Crohn’s disease and ulcerative colitis A. Greenstein, H. Janowitz, D. Sachar. Medicine. 1976. No. 55. Pр. 401–412.Greenstein A. Extra-intestinal complications of Crohn’s disease and ulcerative colitis A. Greenstein, H. Janowitz, D. Sachar. Medicine. 1976. No. 55. Pр. 401–412.Salvarani C. Clinical features and epidemiology of spondylarthritis associated with inflammatory bowel disease. C. Salvarani, W. Fries. World J Gastroenterol. 2009. No. 15 (20). Alvilde M Ossum, et al. P. 2449–2455.Salvarani C. Clinical features and epidemiology of spondylarthritis associated with inflammatory bowel disease. C. Salvarani, W. Fries. World J Gastroenterol. 2009. No. 15 (20). Alvilde M Ossum, et al. P. 2449–2455.Turkcapar N. et al. The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease. Rheumatology International. 2006. V. 26. P. 663–668.Turkcapar N. et al. The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease. Rheumatology International. 2006. V. 26. P. 663–668.Rudwaleit M. Referral strategies for early diagnosis of axial spondyloarthritis. M. Rudwaleit, J. Sieper. Nature Reviews Rheumatology. 2012. No. 8 (5). P. 262–268.Rudwaleit M. Referral strategies for early diagnosis of axial spondyloarthritis. M. Rudwaleit, J. Sieper. Nature Reviews Rheumatology. 2012. No. 8 (5). P. 262–268.Sieper J. et al. New criteria for inflammatory back pain in patients with chronic back pain: A real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS). Annals of the Rheumatic Diseases. 2009. V. 68. No. 6. P. 784–788.Sieper J. et al. New criteria for inflammatory back pain in patients with chronic back pain: A real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS). Annals of the Rheumatic Diseases. 2009. V. 68. No. 6. P. 784–788.Alvilde M. Ossum, et al. Ankylosing Spondylitis and Axial Spondyloarthritis in Patients with Long-term Inflammatory Bowel Disease: Results From 20 Years of Follow-up in the IBSEN Study. Alvilde M Ossum [et al.]. Journal of Crohn's and Colitis. 2018. Vol. 12. No. 1. P. 96–104.Alvilde M. Ossum, et al. Ankylosing Spondylitis and Axial Spondyloarthritis in Patients with Long-term Inflammatory Bowel Disease: Results From 20 Years of Follow-up in the IBSEN Study. Alvilde M Ossum [et al.]. Journal of Crohn's and Colitis. 2018. Vol. 12. No. 1. P. 96–104.Elding S. W. Refinement in localization and identification of gene regions associated with Crohn disease. S.W. Elding [et al.]. American Journal of Human Genetics. 2013. Vol. 92. No. 1. Р. 107–113.Elding S. W. Refinement in localization and identification of gene regions associated with Crohn disease. S.W. Elding [et al.]. American Journal of Human Genetics. 2013. Vol. 92. No. 1. Р. 107–113.Thjodleifsson B. A common genetic background for inflammatory bowel disease and ankylosing spondylitis: A genealogic study in Iceland. B. Thjodleifsson [et al.]. Arthritis and Rheumatism. 2007. Vol. 56. No. 8. Р. 2633–2639.Thjodleifsson B. A common genetic background for inflammatory bowel disease and ankylosing spondylitis: A genealogic study in Iceland. B. Thjodleifsson [et al.]. Arthritis and Rheumatism. 2007. Vol. 56. No. 8. Р. 2633–2639.Asquith M. The interaction between host genetics and the microbiome in the pathogenesis of spondyloarthropathies. M. Asquith, J. T. Rosenbaum. Current Opinion in Rheumatology. 2016. Vol. 28. No. 4. Р. 405–412.Asquith M. The interaction between host genetics and the microbiome in the pathogenesis of spondyloarthropathies. M. Asquith, J. T. Rosenbaum. Current Opinion in Rheumatology. 2016. Vol. 28. No. 4. Р. 405–412.Van Praet L. Microscopic gut inflammation in axial spondyloarthritis: A multiparametric predictive model. L. Van Praet [et al.]. Annals of the Rheumatic Diseases. 2013. Vol. 72. No. 3. Р. 414–417.Van Praet L. Microscopic gut inflammation in axial spondyloarthritis: A multiparametric predictive model. L. Van Praet [et al.]. Annals of the Rheumatic Diseases. 2013. Vol. 72. No. 3. Р. 414–417.Matzkies F. G. Markers of intestinal inflammation in patients with ankylosing spondylitis: A pilot study. F. G. Matzkies [et al.] Arthritis Research and Therapy. 2012. Vol. 14. No. 6. Р. R261.Matzkies F. G. Markers of intestinal inflammation in patients with ankylosing spondylitis: A pilot study. F. G. Matzkies [et al.] Arthritis Research and Therapy. 2012. Vol. 14. No. 6. Р. R261.Абдулганиева Д. И. и др. Проект междисциплинарных рекомендаций по диагностике, методам оценки степени активности воспалительного процесса, терапевтической эффективности и применению генно-инженерных биологических препаратов у пациентов с сочетанными иммуновоспалительными заболеваниями (псориаз, псориатический артрит, болезнь Крона). Альманах клинической медицины. 2018. Т. 46. № 5. С. 426–444. DOI: 10.18786/2072–0505–2018–46–5–426–444.Abdulganieva D.I., at al. A draft of the interdisciplinary guidelines for diagnosis, methods for assessment of the degree of inflammatory activity, therapeutic efficacy, and for the use of biological agents in patients with concomitant immunoinflammatory diseases (psoriasis, psoriatic arthritis, Crohn's disease). Almanac of Clinical Medicine. 2018. Vol. 46. No. 5. P. 426–444. DOI: 10.18786/2072–0505–2018–46–5–426–444.

The authors declare that there are no conflicts of interest present.